![](/img/cover-not-exists.png)
PIN30 USE OF NET-BENEFIT REGRESSION FRAMEWORK TO INVESTIGATE THE COST-EFFECTIVENESS OF COMBINATION ANTIVIRAL THERAPY AMONG HCV-INFECTED PATIENTS ENROLLED IN A MANAGED CARE ORGANIZATION
Hsu, CN, Kauf, TLVolume:
12
Language:
english
Journal:
Value in Health
DOI:
10.1016/S1098-3015(10)75088-9
Date:
October, 2009
File:
PDF, 100 KB
english, 2009